发明名称 BIOENHANCED FORMULATIONS COMPRISING EPROSARTAN IN ORAL SOLID DOSAGE FORM
摘要 This invention relates to bioenhanced formulations comprising eprosartan or eprosartan mesylate in the amorphous form, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure.
申请公布号 CA2338256(C) 申请公布日期 2008.09.23
申请号 CA19992338256 申请日期 1999.07.20
申请人 SMITHKLINE BEECHAM CORPORATION 发明人 VENKATESH, GOPADI;GUDIPATI, MANGA R.
分类号 A61K31/4178;A61K9/14;A61K9/16;A61K9/20;A61K9/26;A61K31/138;A61K31/341;A61K31/401;A61K31/415;A61K31/44;A61K31/4409;A61K31/4422;A61K31/54;A61K31/549;A61K31/635;A61K47/32;A61P9/04;A61P9/12;A61P13/12;A61P43/00 主分类号 A61K31/4178
代理机构 代理人
主权项
地址